Printed from https://ideas.repec.org/s/spr/aphecp4.html
Content
August 2017, Volume 15, Issue 4
- 539-539 Erratum to: Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance
by Iain Willits & Helen Cole & Roseanne Jones & Kimberley Carter & Mick Arber & Michelle Jenks & Joyce Craig & Andrew Sims
June 2017, Volume 15, Issue 3
- 287-289 Aligning Health Economics Methods to Fit with the Changing World of Public Health
by Emma Frew - 291-297 Malaria and Economic Evaluation Methods: Challenges and Opportunities
by Tom L. Drake & Yoel Lubell - 299-306 Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
by Tom L. Drake & Yoel Lubell & Shwe Sin Kyaw & Angela Devine & Myat Phone Kyaw & Nicholas P. J. Day & Frank M. Smithuis & Lisa J. White - 307-321 How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries
by Sabine Vogler & Valérie Paris & Alessandra Ferrario & Veronika J. Wirtz & Kees Joncheere & Peter Schneider & Hanne Bak Pedersen & Guillaume Dedet & Zaheer-Ud-Din Babar - 323-331 Screen Time and Health Indicators Among Children and Youth: Current Evidence, Limitations and Future Directions
by Travis J. Saunders & Jeff K. Vallance - 333-351 Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review
by Irmgard C. Schiller-Frühwirth & Beate Jahn & Marjan Arvandi & Uwe Siebert - 353-362 Does Insurance Status Influence a Patient’s Hospital Charge?
by Lindsey Woodworth & Patrick S. Romano & James F. Holmes - 363-374 Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective
by Zanfina Ademi & Kumar Pasupathi & Danny Liew - 375-384 Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives
by Katharine S. Gries & Dean A. Regier & Scott D. Ramsey & Donald L. Patrick - 385-398 Can a Circular Payment Card Format Effectively Elicit Preferences? Evidence From a Survey on a Mandatory Health Insurance Scheme in Tunisia
by Olivier Chanel & Khaled Makhloufi & Mohammad Abu-Zaineh - 399-412 An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care
by Julie Ratcliffe & Thomas Flint & Tiffany Easton & Maggie Killington & Ian Cameron & Owen Davies & Craig Whitehead & Susan Kurrle & Michelle Miller & Enwu Liu & Maria Crotty - 413-424 Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease
by Sabrina Storgaard Sørensen & Kjeld Møller Pedersen & Ulla Møller Weinreich & Lars Ehlers - 425-433 Assessing Equity in the Provision of Primary Healthcare Centers in Buenos Aires Province (Argentina): A Stochastic Frontier Analysis
by Florencia Arnaudo & Fernando Lago & Valentina Viego - 435-435 Erratum to: Malaria and Economic Evaluation Methods: Challenges and Opportunities
by Tom L. Drake & Yoel Lubell
April 2017, Volume 15, Issue 2
- 119-126 Ethical Hurdles in the Prioritization of Oncology Care
by Folkert Groot & Stefano Capri & Jean-Claude Castanier & David Cunningham & Bruno Flamion & Mathias Flume & Harald Herholz & Lars-Åke Levin & Oriol Solà-Morales & Christoph J. Rupprecht & Natalie Shalet & Andrew Walker & Olivier Wong - 127-137 EQ-5D and the EuroQol Group: Past, Present and Future
by Nancy J. Devlin & Richard Brooks - 139-154 Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance
by Jennifer A. Summers & Muralikrishnan Radhakrishnan & Elizabeth Morris & Anastasia Chalkidou & Tiago Rua & Anita Patel & Viktoria McMillan & Abdel Douiri & Yanzhong Wang & Salma Ayis & Joanne Higgins & Stephen Keevil & Cornelius Lewis & Janet Peacock - 155-162 Amplifying Each Patient’s Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients
by Kevin Marsh & J. Jaime Caro & Alaa Hamed & Erica Zaiser - 163-172 Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil
by Alessandro G. Campolina & Luciana M. Rozman & Tassia C. Decimoni & Roseli Leandro & Hillegonda M. D. Novaes & Patrícia Coelho De Soárez - 173-201 Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review
by Lazaros Andronis & Philip Kinghorn & Suyin Qiao & David G. T. Whitehurst & Susie Durrell & Hugh McLeod - 203-214 Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat
by Kathleen A. Fairman & Lindsay E. Davis & Courtney R. Kruse & David A. Sclar - 215-226 Determinants of Voluntary National Health Insurance Drop-Out in Eastern Sudan
by Chantal Herberholz & Wael Ahmed Fakihammed - 227-235 Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval
by James D. Chambers & Teja Thorat & Colby L. Wilkinson & Mark Salem & Prasun Subedi & Sachin J. Kamal-Bahl & Peter J. Neumann - 237-248 Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
by Åsa Ericsson & Adam Lundqvist - 249-259 Sustaining Gains in Health Programs: Technical Efficiency and its Determinants in Malaria Programs in Sub-Saharan Africa
by Esso-Hanam Atake - 261-276 Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model
by L. Gerlier & M. Lamotte & S. Grenèche & X. Lenne & F. Carrat & C. Weil-Olivier & O. Damm & M. Schwehm & M. Eichner - 277-286 Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia
by August Cesarec & Robert Likić
February 2017, Volume 15, Issue 1
- 1-3 ‘Appropriateness’ in Italy: A ‘Magic Word’ in Pharmaceuticals?
by Livio Garattini & Anna Padula - 5-11 The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements
by Mondher Toumi & Szymon Jarosławski & Toyohiro Sawada & Åsa Kornfeld - 13-21 Economic Crisis, Austerity Policies, Health and Fairness: Lessons Learned in Spain
by Beatriz G. Lopez-Valcarcel & Patricia Barber - 23-32 Health State Utility Values for Age-Related Macular Degeneration: Review and Advice
by Thomas Butt & Adnan Tufail & Gary Rubin - 33-43 Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers
by Elias Asfaw Zegeye & Josue Mbonigaba & Sylvia Blanche Kaye & Thomas Wilkinson - 45-55 Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data
by Istvan Majer & Gijs Wetering & Zoltan Polanyi & Arun Krishna & Elisabeth Gray & Anuja Roy - 57-64 Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China
by Yuqing Tang & Chaojie Liu & Xinping Zhang - 65-74 Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease
by Andrew J. Leidner & Harrell W. Chesson & Philip R. Spradling & Scott D. Holmberg - 75-83 The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients
by Yue Zhong & Joshua T. Cohen & Scott Goates & Menghua Luo & Jeffrey Nelson & Peter J. Neumann - 85-93 Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications
by Marina Kostić & Ljiljan Djakovic & Raša Šujić & Brian Godman & Slobodan M. Janković - 95-111 A Cost-Utility Analysis of Prostate Cancer Screening in Australia
by Andrew Keller & Christian Gericke & Jennifer A. Whitty & John Yaxley & Boon Kua & Geoff Coughlin & Troy Gianduzzo - 113-118 Promoting Antibacterial Drug Development: Select Policies and Challenges
by Aylin Sertkaya & Amber Jessup & Hui-Hsing Wong
December 2016, Volume 14, Issue 6
- 623-634 Review of Economic Submissions to NICE Medical Technologies Evaluation Programme
by Abualbishr Alshreef & Michelle Jenks & William Green & Simon Dixon - 635-646 Parafricta Bootees and Undergarments to Reduce Skin Breakdown in People with or at Risk of Pressure Ulcers: A NICE Medical Technologies Guidance
by Catherine Meads & Matthew Glover & Paul Dimmock & Subhash Pokhrel - 647-657 Possible Impact of Incremental Cost-Effectiveness Ratio (ICER) on Decision Making for Cancer Screening in Hong Kong: A Systematic Review
by Carlos K. H. Wong & Brian H. H. Lang & Vivian Y. W. Guo & Cindy L. K. Lam - 659-672 A Systematic Review of Economic Evaluation Methodologies Between Resource-Limited and Resource-Rich Countries: A Case of Rotavirus Vaccines
by Kittiphong Thiboonboon & Benjarin Santatiwongchai & Varit Chantarastapornchit & Waranya Rattanavipapong & Yot Teerawattananon - 673-690 India’s Proposed Universal Health Coverage Policy: Evidence for Age Structure Transition Effect and Fiscal Sustainability
by Muttur Ranganathan Narayana - 691-701 Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany
by Florian Hofer & Dmitrij Achelrod & Tom Stargardt - 703-718 The Cost and Outcome Effectiveness of Total Hip Replacement: Technique Choice and Volume–Output Effects Matter
by Jonathan P. Goldstein & George M. Babikian & Adam J. Rana & Johanna A. Mackenzie & Andrew Millar - 719-727 Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands
by Vassilis Fragoulakis & Chris P. Pescott & Jesper M. J. Smeenk & Evert J. P. Santbrink & G. Jur E. Oosterhuis & Frank J. M. Broekmans & Nikos Maniadakis - 729-730 Comment on: “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”
by Afschin Gandjour - 731-732 Authors’ Reply to Gandjour “The Cost Effectiveness of High-Dose Versus Conventional Haemodialysis: A Systematic Review”
by Suzanne Laplante & Frank X. Liu & Bruce Culleton & Angelito Bernardo & Denise King & Pollyanna Hudson - 733-734 A Review of “Cost Effectiveness Modelling for Health Technology Assessment: A Practical Course”
by Ahmed Abdulla & Angela Stainthorpe
October 2016, Volume 14, Issue 5
- 507-509 Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?
by Afschin Gandjour - 511-514 Supporting Medicare Health, Equity and Efficiency in Australia: Policies Undermining Bulk Billing Need to Be Scrapped
by Simon Eckermann & Lynnaire Sheridan - 515-526 The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance
by Alistair Ray & Helen Morgan & Antony Wilkes & Kimberley Carter & Grace Carolan-Rees - 527-543 Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review
by Miriam Luhnen & Siw Waffenschmidt & Andreas Gerber-Grote & Gloria Hanke - 545-558 Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK
by Stephen Montgomery & Jeanette Kusel & Felicity Allen & Nicholas Adlard - 559-568 A Qualitative Evaluation of Program Budgeting and Marginal Analysis in a Canadian Pediatric Tertiary Care Institution
by Neale Smith & Craig Mitton & Mary-Ann Hiltz & Matthew Campbell & Laura Dowling & J. Fergall Magee & Shashi Ashok Gujar - 569-578 Barrier to Access or Cost Share? Coinsurance and Dental-Care Utilization in Colombia
by Lucas Higuera & Sergio Iván Prada - 579-594 Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal
by M. Reza Maleki-Yazdi & Mathieu Molimard & Dorothy L. Keininger & Jean-Bernard Gruenberger & Joao Carrasco & Claudia Pitotti & Elsa Sauvage & Sara Chehab & David Price - 595-607 Care Appropriateness and Health Productivity Evolution: A Non-Parametric Analysis of the Italian Regional Health Systems
by Paolo Mancuso & Vivian Grace Valdmanis - 609-617 Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion
by Katherine M. Prioli & Laura T. Pizzi & Julie Katz Karp & Taki Galanis & Jay H. Herman
August 2016, Volume 14, Issue 4
- 397-400 The Potential Impact of the Trans-Pacific Partnership Agreement on Health Equity, with Illustration From New Zealand
by Gay Keating & Rhys Jones & Erik Monasterio & Josh Freeman - 401-407 Governments Need Better Guidance to Maximise Value for Money: The Case of Australia’s Pharmaceutical Benefits Advisory Committee
by Drew Carter & Arlene Vogan & Hossein Haji Ali Afzali - 409-418 Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review
by Adam J. N. Raymakers & John Mayo & Stephen Lam & J. Mark FitzGerald & David G. T. Whitehurst & Larry D. Lynd - 419-429 Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups
by Huanxue Zhou & Christopher Taber & Steve Arcona & Yunfeng Li - 431-440 Economic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses
by Manal H. El-Hamamsy & Gihan H. Elsisi & Randa Eldessouki & Mohamed M. Elmazar & Ahmed S. Taha & Basma F. Awad & Hossam Elmansy - 441-452 Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany
by I. Aumann & M. Treskova & N. Hagemann & J.-M. Schulenburg - 453-464 Measuring the Volume-Outcome Relation for Complex Hospital Surgery
by Woohyeon Kim & Stephen Wolff & Vivian Ho - 465-477 Cost-Effectiveness Analysis of Bendamustine Plus Rituximab as a First-Line Treatment for Patients with Follicular Lymphoma in Spain
by Eliazar Sabater & Armando López-Guillermo & Antonio Rueda & Antonio Salar & Itziar Oyagüez & Juan Manuel Collar - 479-491 The Efficiency of Increasing the Capacity of Physiotherapy Screening Clinics or Traditional Medical Services to Address Unmet Demand in Orthopaedic Outpatients: A Practical Application of Discrete Event Simulation with Dynamic Queuing
by L. Standfield & T. Comans & M. Raymer & S. O’Leary & N. Moretto & P. Scuffham - 493-505 A Trial-Based Predictive Microsimulation Assessing the Public Health Benefits of Nalmefene and Psychosocial Support for the Reduction of Alcohol Consumption in Alcohol Dependence
by Philippe Laramée & Aurélie Millier & Nora Rahhali & Olivier Cristeau & Samuel Aballéa & Clément François & Ylana Chalem & Mondher Toumi & Jürgen Rehm
June 2016, Volume 14, Issue 3
- 245-252 Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
by Mark Jit & Raymond Hutubessy - 267-279 The TURis System for Transurethral Resection of the Prostate: A NICE Medical Technology Guidance
by Andrew Cleves & Paul Dimmock & Neil Hewitt & Grace Carolan-Rees - 293-312 Key Aspects of a Sustainable Health Insurance System in Germany
by Matthias Pelster & Vera Hagemann & Franziska Laporte Uribe - 313-322 Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation
by Amy Tawfik & Walter P. Wodchis & Petros Pechlivanoglou & Jeffrey Hoch & Don Husereau & Murray Krahn - 323-335 Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis
by Yuko Saruta & Jaume Puig-Junoy - 337-347 Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis
by Samer Hamidi & Fevzi Akinci - 349-359 The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations
by Ali Moghtaderi & Scott Adams - 375-385 Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making
by Takeru Shiroiwa & Shinya Saito & Kojiro Shimozuma & Satoshi Kodama & Shinichi Noto & Takashi Fukuda
April 2016, Volume 14, Issue 2
- 127-128 A Review of “The New Drug Reimbursement Game: A Regulator’s Guide to Playing and Winning”
by Christopher J. McCabe - 135-149 Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance
by Michelle Jenks & Joyce Craig & William Green & Neil Hewitt & Mick Arber & Andrew Sims - 151-159 A Scoping Review of Healthcare Costs for Patients with Cystic Fibrosis
by Ilene L. Hollin & Karen A. Robinson - 161-183 A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health
by Elizabeth Goodwin & Colin Green - 185-193 The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review
by S. Laplante & F. X. Liu & B. Culleton & A. Bernardo & Denise King & P. Hudson - 195-204 Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment
by Sachiko Ozawa & Simrun Grewal & John F.P. Bridges - 205-215 The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke’s Encephalopathy Presenting at the Emergency Department
by Edward C. F. Wilson & George Stanley & Zulfiquar Mirza - 217-227 Formal Professional Relationships Between General Practitioners and Specialists in Shared Care: Possible Associations with Patient Health and Pharmacy Costs
by Ágnes Lublóy & Judit Lilla Keresztúri & Gábor Benedek - 229-240 Effectiveness and Cost of a Personalized Reminder Intervention to Improve Adherence to Glaucoma Care
by Laura T. Pizzi & Judie Tran & Anousheh Shafa & Michael Waisbourd & Lisa Hark & Ann P. Murchison & Yang Dai & Eileen L. Mayro & Julia A. Haller - 241-241 Comment on: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011”
by Afschin Gandjour - 243-243 Authors’ Reply to Gandjour: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011”
by Kenneth E. Thorpe & Lindsay Allen & Peter Joski
February 2016, Volume 14, Issue 1
- 9-20 Why ‘Optimal’ Payment for Healthcare Providers Can Never be Optimal Under Community Rating
by Peter Zweifel & H. E. Frech - 29-40 Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA
by Axel C. Mühlbacher & Anika Kaczynski - 77-87 Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation
by Ataru Igarashi & Rei Goto & Kiyomi Suwa & Reiko Yoshikawa & Alexandra J. Ward & Jörgen Moller - 89-104 Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness
by Donna Rowen & John Brazier & Anju Keetharuth & Aki Tsuchiya & Clara Mukuria - 117-118 Comment on: “Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists”
by Carl Samuelsen & Eric D. Bateman & Ian Pavord & Adam Lloyd & Mike Baldwin & Dirk Esser - 119-125 Erratum to: Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists
by Jenny Willson & Eric D. Bateman & Ian Pavord & Adam Lloyd & Tania Krivasi & Dirk Esser
December 2015, Volume 13, Issue 6
- 557-565 Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
by John Brazier & Aki Tsuchiya - 567-581 Estimating the Costs of Torture: Challenges and Opportunities
by Emmanuel Mpinga & Ngianga-Bakwin Kandala & Jennifer Hasselgård-Rowe & Félicien Tshimungu Kandolo & Henk Verloo & Ngoyi Bukonda & Philippe Chastonay - 583-594 The Debrisoft ® Monofilament Debridement Pad for Use in Acute or Chronic Wounds: A NICE Medical Technology Guidance
by Catherine Meads & Eleonora Lovato & Louise Longworth - 595-613 A Systematic Review of the State of Economic Evaluation for Health Care in India
by Shankar Prinja & Akashdeep Chauhan & Blake Angell & Indrani Gupta & Stephen Jan - 615-626 The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
by Stuart Wright & Cheryl Jones & Katherine Payne & Nimarta Dharni & Fiona Ulph - 627-635 Hospital Utilization and Universal Health Insurance Coverage: Evidence from the Massachusetts Health Care Reform Act
by Attila Cseh & Brandon Koford & Ryan Phelps - 637-645 Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
by Madlaina Costa-Scharplatz & Björn Ställberg & Pankaj Goyal & Yumi Asukai & Jean-Bernard Gruenberger & David Price - 647-659 Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study
by Renee Lévesque & Daniele Marcelli & Héloïse Cardinal & Marie-Line Caron & Muriel Grooteman & Michiel Bots & Peter Blankestijn & Menso Nubé & Aileen Grassmann & Bernard Canaud & Afschin Gandjour
October 2015, Volume 13, Issue 5
- 433-435 Medicare’s Mission to Change How Health Care is Paid for and Delivered: A Cloud with a Silver Lining or Just a Dark Cloud?
by Jeffrey Voigt - 437-443 Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
by Stavros Petrou & Oliver Rivero-Arias & Helen Dakin & Louise Longworth & Mark Oppe & Robert Froud & Alastair Gray - 445-456 Vision Amniotic Leak Detector (ALD) to Eliminate Amniotic Fluid Leakage as a Cause of Vaginal Wetness in Pregnancy: A NICE Medical Technology Guidance
by A. Ray & S. Peirce & A. Wilkes & G. Carolan-Rees - 457-467 A Systematic Review of Economic Evaluations of the Use of Robotic Assisted Laparoscopy in Surgery Compared with Open or Laparoscopic Surgery
by Zafer Tandogdu & Luke Vale & Cynthia Fraser & Craig Ramsay - 469-483 A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis
by Barbara Graaff & Amanda Neil & Kristy Sanderson & Lei Si & Kwang Yee & Andrew Palmer - 485-492 Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study
by Julie Ratcliffe & Gang Chen & Katherine Stevens & Sandra Bradley & Leah Couzner & John Brazier & Michael Sawyer & Rachel Roberts & Elisabeth Huynh & Terry Flynn - 493-506 A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda
by Solomon Lubinga & Byamah Mutamba & Angelo Nganizi & Joseph Babigumira - 507-514 The Robustness and Effectiveness of the Triage System at Times of Overcrowding and the Extra Costs due to Inappropriate Use of Emergency Departments
by Paolo Cremonesi & Enrico Bella & Marcello Montefiori & Luca Persico - 515-523 An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in Cyprus
by Panagiotis Petrou - 525-542 Cost-Effectiveness of School-Based Prevention of Cannabis Use
by Charlotte Deogan & Natalie Zarabi & Nils Stenström & Pi Högberg & Eva Skärstrand & Edison Manrique-Garcia & Kristian Neovius & Anna Månsdotter - 543-551 Implementing Guidelines: The Cost and Clinical Impact of Anticoagulants in the UK Atrial Fibrillation Population
by Gemma Shields & Alexander Bates & Ann-Marie Chapman
August 2015, Volume 13, Issue 4
- 311-313 The Value of Productivity in Health Policy
by Wilbert Van den Hout - 315-324 VibraTip™ for Testing Vibration Perception to Detect Diabetic Peripheral Neuropathy: A NICE Medical Technology Guidance
by Iain Willits & Helen Cole & Roseanne Jones & Paul Dimmock & Mick Arber & Joyce Craig & Andrew Sims - 325-340 A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection
by Jonathon Campbell & Thenuga Sasitharan & Fawziah Marra - 341-357 US and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review
by Michael Harvey & Michael Gaies & Lisa Prosser - 359-367 Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches
by Alison Pearce & Paul Hanly & Aileen Timmons & Paul Walsh & Ciaran O’Neill & Eleanor O’Sullivan & Rachael Gooberman-Hill & Audrey Thomas & Pamela Gallagher & Linda Sharp - 369-379 Impact of a Dynamic Microbiological Environment on the Clinical Efficacy of Ertapenem and Piperacillin/Tazobactam in the Treatment of Complicated Community-Acquired Intra-Abdominal Infection in Spain: A Cost-Consequence Analysis
by Santiago Grau & Virginia Lozano & Amparo Valladares & Rafael Cavanillas & Yang Xie & Gonzalo Nocea - 381-387 The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011
by Kenneth Thorpe & Lindsay Allen & Peter Joski - 389-397 Equitable Prices of Single-Source Drugs in Thailand
by Surachat Ngorsuraches & Kanokkan Chaiyakan - 399-407 Health Economic Evaluation of a Strict Glucose Control Guideline Implemented Using Point-of-Care Testing in Three Intensive Care Units in The Netherlands
by Roosmarijn Hooijdonk & Lotte Steuten & Michelle Kip & Helma Monteban & Marianne Mulder & Floris Braam Houckgeest & Johannes Sluijs & Ameen Abu-Hanna & Peter Spronk & Marcus Schultz - 409-420 A Comparison of Japan and UK SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method
by Samer Kharroubi - 421-432 Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability
by G. Sagoo & S. Mohammed & G. Barton & G. Norbury & J. Ahn & C. Ogilvie & M. Kroese
June 2015, Volume 13, Issue 3
- 265-267 An Economist’s Influence on Health Policy
by Peter Zweifel - 269-271 Cost-Effectiveness Analysis: A View into the Abyss
by Paul Kind - 273-279 How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?
by Don Husereau & Anthony Culyer & Peter Neumann & Philip Jacobs - 281-289 Health Economics and Health Policy: Experiences from New Zealand
by Jacqueline Cumming - 291-302 Health Technology Assessment of Cancer Drugs in Canada, the United Kingdom and Australia: Should the United States Take Notice?
by George Dranitsaris & George Papadopoulos - 303-309 Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake
by Gregory Merlo & Katie Page & Julie Ratcliffe & Kate Halton & Nicholas Graves
April 2015, Volume 13, Issue 2
- 121-123 The Case of Penny Wise but Access and Quality of Care Foolish
by Jeffrey Voigt - 125-127 Biosimilar Versus Generic Drugs: Same But Different?
by Katelijne Vooren & Alessandro Curto & Livio Garattini - 129-133 Measuring the Cost Effectiveness of HIV Prevention Interventions in the US: Pitfalls and Problems
by Fred Hellinger - 135-147 The geko™ Electro-Stimulation Device for Venous Thromboembolism Prophylaxis: A NICE Medical Technology Guidance
by Jennifer Summers & James Clinch & Muralikrishnan Radhakrishnan & Andy Healy & Viktoria McMillan & Elizabeth Morris & Tiago Rua & Mercy Ofuya & Yanzhong Wang & Paul Dimmock & Cornelius Lewis & Janet Peacock & Stephen Keevil - 149-156 A Systematic Review on Cost Effectiveness of HIV Prevention Interventions in the United States
by Ya-Lin Huang & Arielle Lasry & Angela Hutchinson & Stephanie Sansom - 157-166 Funding, Coverage, and Access Under Thailand’s Universal Health Insurance Program: An Update After Ten Years
by Kannika Damrongplasit & Glenn Melnick - 167-179 Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later
by Haitham Tuffaha & Shelley Roberts & Wendy Chaboyer & Louisa Gordon & Paul Scuffham - 181-192 Opioid Misuse Among Adolescents: New Evidence from a Misclassification Analysis
by Sean Murphy & Daniel Friesner & Robert Rosenman - 193-205 Potential Savings in Prescription Drug Costs for Hypertension, Hyperlipidemia, and Diabetes Mellitus by Equivalent Drug Substitution in Austria: A Nationwide Cohort Study
by Georg Heinze & Milan Hronsky & Berthold Reichardt & Christoph Baumgärtel & Marcus Müllner & Anna Bucsics & Wolfgang Winkelmayer - 207-222 The Impact of Pharmaceutical Innovation on Premature Mortality, Cancer Mortality, and Hospitalization in Slovenia, 1997–2010
by Frank Lichtenberg - 223-231 An Estimation of the Value of Informal Care Provided to Dependent People in Spain
by Juan Oliva-Moreno & Luz Peña-Longobardo & Cristina Vilaplana-Prieto - 233-242 Economic Analysis of Thrombo inCode, a Clinical–Genetic Function for Assessing the Risk of Venous Thromboembolism
by C. Rubio-Terrés & J. Soria & P. Morange & J. Souto & P. Suchon & J. Mateo & N. Saut & D. Rubio-Rodríguez & J. Sala & A. Gracia & S. Pich & E. Salas - 243-251 A Prediction Model of Childhood Immunization Rates
by Elizabeth Crouch & Lori Dickes - 253-263 Prospective Randomized Controlled Trial Comparing the Outcomes and Costs of Two Eyecare Adherence Interventions in Diabetes Patients
by Laura Pizzi & Camila Zangalli & Ann Murchison & Nicole Hale & Lisa Hark & Yang Dai & Benjamin Leiby & Julia Haller
August 2015, Volume 13, Issue 1
- 3-4 Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?
by Livio Garattini & Katelijne Vooren - 5-11 Definition and Classification of Generic Drugs Across the World
by Rafael Alfonso-Cristancho & Tatiana Andia & Tatiana Barbosa & Jonathan Watanabe - 13-20 A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators
by Shanlian Hu & Yabing Zhang & Jiangjiang He & Lixia Du & Mingfei Xu & Chunyan Xie & Ying Peng & Linan Wang - 21-33 The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review
by H. Gothe & I. Schall & K. Saverno & M. Mitrovic & A. Luzak & D. Brixner & U. Siebert - 35-45 A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?
by Else-Lydia Toverud & Katrin Hartmann & Helle Håkonsen
February 2015, Volume 13, Issue 1
- 1-6 Systematic Overuse of Healthcare Services: A Conceptual Model
by Najlla Nassery & Jodi Segal & Eva Chang & John Bridges - 7-13 Kinky Thresholds Revisited: Opportunity Costs Differ in the NE and SW Quadrants
by Simon Eckermann - 15-27 A Review of the Economic Tools for Assessing New Medical Devices
by Joyce Craig & Louise Carr & John Hutton & Julie Glanville & Cynthia Iglesias & Andrew Sims - 29-45 Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared with Medical Management or Surgery for Patients with Aortic Stenosis
by Andrea Iannaccone & Thomas Marwick - 47-59 Biosimilar Versus Patented Erythropoietins: Learning from 5 Years of European and Japanese Experience
by François Bocquet & Pascal Paubel & Isabelle Fusier & Anne-Laure Cordonnier & Martine Sinègre & Claude Le Pen - 61-68 Direct Costs of Unintended Pregnancy in the Russian Federation
by Julia Lowin & James Jarrett & Maria Dimova & Victoria Ignateva & Vitaly Omelyanovsky & Anna Filonenko - 69-80 Healthcare Costs Associated with Antiretroviral Adherence Among Medicaid Patients
by Zachary Pruitt & John Robst & Barbara Langland-Orban & Robert Brooks - 81-94 Comparing Willingness to Pay for Improved Drinking-Water Quality Using Stated Preference Methods in Rural and Urban Kenya
by Roy Brouwer & Fumbi Job & Bianca Kroon & Richard Johnston - 95-107 Cost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
by Warner Huh & Erin Williams & Joice Huang & Tommy Bramley & Nick Poulios - 109-120 Migraine-Related Healthcare Resource Use and Costs for Subjects Prescribed Fixed-Dose Combination Sumatriptan/Naproxen Sodium vs. Single-Entity Oral Triptans in a Managed Care Population in the USA
by M. Runken & Bridgett Goodwin & Manan Shah & Michael Eaddy & Anna D’Souza & Brian Bowers & Christopher Bell
December 2014, Volume 12, Issue 6
- 573-585 Using Decision Trees to Manage Hospital Readmission Risk for Acute Myocardial Infarction, Heart Failure, and Pneumonia
by John Hilbert & Scott Zasadil & Donna Keyser & Pamela Peele - 587-599 The MAGEC System for Spinal Lengthening in Children with Scoliosis: A NICE Medical Technology Guidance
by Michelle Jenks & Joyce Craig & Joanne Higgins & Iain Willits & Teresa Barata & Hannah Wood & Christine Kimpton & Andrew Sims - 601-610 Willingness to Pay for Health Insurance Among HIV-Positive Patients in India
by Indrani Gupta & Mayur Trivedi - 611-622 Cost Effectiveness of Renal Denervation Therapy for the Treatment of Resistant Hypertension in the UK
by Daniel Gladwell & Thea Henry & Mark Cook & Ron Akehurst - 623-633 The Importance of Proximity to Death in Modelling Community Medication Expenditures for Older People: Evidence From New Zealand
by Patrick Moore & Kathleen Bennett & Charles Normand - 635-645 Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland
by Emer Fogarty & Cathal Walsh & Christopher McGuigan & Niall Tubridy & Michael Barry - 647-659 Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands
by Aikaterini Vellopoulou & Michel Agthoven & Annemarie Kolk & Robert Knegt & Gilles Berdeaux & Sandrine Cure & Florence Bianic & Mark Lamotte
October 2014, Volume 12, Issue 5
- 471-476 Ethical Objections Against Including Life-Extension Costs in Cost-Effectiveness Analysis: A Consistent Approach
by Afschin Gandjour & Dirk Müller - 477-484 EXOGEN Ultrasound Bone Healing System for Long Bone Fractures with Non-Union or Delayed Healing: A NICE Medical Technology Guidance
by Ailish Higgins & Matthew Glover & Yaling Yang & Susan Bayliss & Catherine Meads & Joanne Lord - 485-495 E-Vita Open Plus for Treating Complex Aneurysms and Dissections of the Thoracic Aorta: A NICE Medical Technology Guidance
by Muralikrishnan Radhakrishnan & Janet Peacock & Tiago Rua & Rachel Clough & Mercy Ofuya & Yanzhong Wang & Elizabeth Morris & Cornelius Lewis & Stephen Keevil - 497-510 What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer
by M. Barbieri & H. Weatherly & R. Ara & H. Basarir & M. Sculpher & R. Adams & H. Ahmed & C. Coles & T. Guerrero-Urbano & C. Nutting & M. Powell - 511-522 Examining the Influence of Antenatal Care Visits and Skilled Delivery on Neonatal Deaths in Ghana
by Monica Lambon-Quayefio & Nkechi Owoo - 523-535 Diagnostic Needle Arthroscopy and the Economics of Improved Diagnostic Accuracy: A Cost Analysis
by Jeffrey Voigt & Michael Mosier & Bryan Huber - 537-546 The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand
by Charon Lessing & Toni Ashton & Peter Davis - 547-557 Comparing Hospital-Based Resource Utilization and Costs for Prostate Cancer Patients With and Without Bone Metastases
by Brian Seal & Sean Sullivan & Scott Ramsey & Carl Asche & Ken Shermock & Syam Sarma & Erin Zagadailov & Eileen Farrelly & Michael Eaddy - 559-560 Comment on: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?”
by Domingos Malerbi - 561-563 Authors’ Reply to Dr. Malerbi: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?”
by Ana Souza & Francisco de Acurcio & Augusto Guerra Júnior & Renata Nascimento & Brian Godman & Leonardo Diniz - 565-565 Comment on: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers”
by Alessandro Curto & Livio Garattini - 567-568 Authors’ Reply to Curto and Garattini: “Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers”
by Josh Carlson & Katie Gries & Kai Yeung & Sean Sullivan & Louis Garrison
August 2014, Volume 12, Issue 4
- 347-357 Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? The Role of NICE’s Medical Technologies Evaluation Programme (MTEP)
by A. Chapman & C. Taylor & A. Girling - 359-372 A Systematic and Critical Review of Model-Based Economic Evaluations of Pharmacotherapeutics in Patients with Bipolar Disorder
by Syed Mohiuddin - 373-389 Economic Evaluations of Guideline-Based or Strategic Interventions for the Prevention or Treatment of Chronic Wounds
by Marissa Carter - 391-408 Systematic Review of the Cost Effectiveness of Radiation Therapy for Prostate Cancer from 2003 to 2013
by Neha Amin & David Sher & Andre Konski - 409-420 Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis from a UK Payer Perspective
by Catrin Treharne & Frank Liu & Murat Arici & Lydia Crowe & Usman Farooqui - 421-433 Disease-Specific Impoverishment Impact of Out-of-Pocket Payments for Health Care: Evidence from Rural Bangladesh
by Syed Hamid & Syed Ahsan & Afroza Begum - 435-446 Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
by J. Rice & Noam Kirson & Amie Shei & Alice Cummings & Katharine Bodnar & Howard Birnbaum & Rami Ben-Joseph - 447-459 Cost Effectiveness of Tiotropium in Patients with Asthma Poorly Controlled on Inhaled Glucocorticosteroids and Long-Acting β-Agonists
by Jenny Willson & Eric Bateman & Ian Pavord & Adam Lloyd & Tania Krivasi & Dirk Esser - 461-470 The Impact of Rural Health Care Accessibility on Cancer-Related Behaviors and Outcomes
by Eric Belasco & Gordon Gong & Barbara Pence & Ethan Wilkes
June 2014, Volume 12, Issue 3
- 231-238 Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers
by Josh Carlson & Katharine Gries & Kai Yeung & Sean Sullivan & Louis Garrison - 239-253 Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods
by P. Watson & L. Preston & H. Squires & J. Chilcott & A. Brennan - 255-265 WatchBP Home A for Opportunistically Detecting Atrial Fibrillation During Diagnosis and Monitoring of Hypertension: A NICE Medical Technology Guidance
by Iain Willits & Kim Keltie & Joyce Craig & Andrew Sims - 267-277 A Systematic Review of Osteoporosis Medication Adherence and Osteoporosis-Related Fracture Costs in Men
by Yeshi Mikyas & Irene Agodoa & Nicole Yurgin - 279-287 Paying for Formerly Free Medicines in Spain After 1 Year of Co-Payment: Changes in the Number of Dispensed Prescriptions
by Jaume Puig-Junoy & Santiago Rodríguez-Feijoó & Beatriz Lopez-Valcarcel - 289-297 Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity
by Thomas Butt & Praveen Patel & Adnan Tufail & Gary Rubin - 299-313 Healthcare Use and Voluntary Health Insurance After Retirement in Thailand
by Papar Kananurak - 315-326 Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in the EU-5 Markets: A Descriptive Analysis
by François Bocquet & Pascal Paubel & Isabelle Fusier & Anne-Laure Cordonnier & Claude Pen & Martine Sinègre - 327-334 Belief Elicitation to Populate Health Economic Models of Medical Diagnostic Devices in Development
by Wieke Haakma & Lotte Steuten & Laura Bojke & Maarten IJzerman